Figures in the Special Focus Profiles

Data represented in many of the figures below can be downloaded at:  https://www.cdc.gov/std/stats18/figures/Figure-Data-Points-for-web.zip ZIP [ZIP – 14 MB]

STDs in Women and Infants

Figure A. Chlamydia — Rates of Reported Cases Among Females by State and Territory, United States, 2018

Figure B. Chlamydia — Positivity Among Females Aged 14–39 Years by Race/Hispanic Ethnicity and Age Group in Clinics Providing Family Planning and Reproductive Health Services, STD Surveillance Network (SSuN), 2018

Figure C. Gonorrhea — Rates of Reported Cases Among Females by State and Territory, United States, 2018

Figure D. Pelvic Inflammatory Disease — Initial Visits to Physicians’ Offices Among Females Aged 15–44 Years, United States, 2007–2016

Figure E. Estimated Percentage of Acute Pelvic Inflammatory Disease Emergency Department Visits Among Females Aged 15–44 Years by Age Group and Year, United States, 2006–2013

Figure F. Pelvic Inflammatory Disease — National Estimates of Lifetime Prevalence Among Sexually Experienced Women Aged 18–44 Years by Race/Hispanic Ethnicity and Previous STD Diagnosis, National Health and Nutrition Examination Survey (NHANES), 2013–2014

Figure G. Ectopic Pregnancy — Ratio Among Commercially Insured Females with Live Births Aged 15–44 Years by Age Group, 2006–2017

Figure H. Chlamydia and Gonorrhea — Rates of Reported Cases Among Infants <1 Year of Age by Year and Specimen Source, United States, 2014–2018

Figure I. Congenital Syphilis — Rates of Reported Cases by State and Territory, United States, 2018

Figure J. Primary and Secondary Syphilis — Rates of Reported Cases Among Females by State and Territory, United States, 2018

STDs in Adolescents and Young Adults

Figure K. Chlamydia — Rates of Reported Cases Among Females Aged 15–24 Years by State and Territory, United States, 2018

Figure L. Chlamydia — Rates of Reported Cases Among Males Aged 15–24 Years by State and Territory, United States, 2018

Figure M. Gonorrhea — Rates of Reported Cases Among Females Aged 15–24 Years by State and Territory, United States, 2018

Figure N. Gonorrhea — Rates of Reported Cases Among Males Aged 15–24 Years by State and Territory, United States, 2018

Figure O. Chlamydia — Prevalence Among Females Aged 16–24 Years Entering the National Job Training Program (NJTP) by State and Territory of Residence, United States, 2018

Figure P. Chlamydia — Prevalence Among Males Aged 16–24 Years Entering the National Job Training Program (NJTP) by State and Territory of Residence, United States, 2018

Figure Q. Gonorrhea — Prevalence Among Females Aged 16–24 Years Entering the National Job Training Program (NJTP) by State and Territory of Residence, United States, 2018

Figure R. Gonorrhea — Prevalence Among Males Aged 16–24 Years Entering the National Job Training Program (NJTP) by State and Territory of Residence, United States, 2018

STDs in Racial and Ethnic Minorities

Figure S. Chlamydia — Rates of Reported Cases by Race/Hispanic Ethnicity and Sex, United States, 2018

Figure T. Chlamydia — Rate Ratios Among Females Aged 15–24 Years by Race/Hispanic Ethnicity and Region, United States, 2018

Figure U. Gonorrhea — Rates of Reported Cases by Race/Hispanic Ethnicity and Sex, United States, 2018

Figure V. Gonorrhea — Rate Ratios by Race/Hispanic Ethnicity and Region, United States, 2018

Figure W. Primary and Secondary Syphilis — Rates of Reported Cases by Race/Hispanic Ethnicity and Sex, United States, 2018

Figure X. Primary and Secondary Syphilis — Rate Ratios by Sex, Race/Hispanic Ethnicity, and Region, United States, 2018

Figure Y. Congenital Syphilis — Rates of Reported Cases by Year of Birth and Race/Hispanic Ethnicity of Mother, United States, 2009–2018

Figure Z. Primary and Secondary Syphilis — Reported Cases by Sex and Sex of Sex Partners and Race/Hispanic Ethnicity, United States, 2018

STDs in Men who Have Sex with Men

Figure AA. Primary and Secondary Syphilis — Estimated Rates of Reported Cases Among MSM by State, United States, 2018

Figure BB. Neisseria gonorrhoeae — Percentage of Urethral Isolates Obtained from MSM Attending STD Clinics, Gonococcal Isolate Surveillance Project (GISP), 1989–2018

Figure CC. Neisseria gonorrhoeae — Percentage of Urethral Isolates with Elevated Minimum Inhibitory Concentrations (MICs) to Azithromycin and Ceftriaxone by Sex and Sex of Sex Partners, Gonococcal Isolate Surveillance Project (GISP), 2009–2018

Figure DD. Gonorrhea and Chlamydia — Proportion of MSM STD Clinic Patients Tested and Testing Positive for Urogenital Gonorrhea and Chlamydia by Jurisdiction, STD Surveillance Network (SSuN), 2018

Figure EE. Gonorrhea and Chlamydia — Proportion of MSM STD Clinic Patients Tested and Testing Positive for Rectal Gonorrhea and Chlamydia by Jurisdiction, STD Surveillance Network (SSuN), 2018

Figure FF. Gonorrhea and Chlamydia — Proportion of MSM STD Clinic Patients Tested and Testing Positive for Pharyngeal Gonorrhea and Chlamydia by Jurisdiction, STD Surveillance Network (SSuN), 2018

Figure GG. Proportion of MSM Attending STD Clinics with Primary and Secondary Syphilis, Urogenital Gonorrhea, or Urogenital Chlamydia by Known HIV Status, STD Surveillance Network (SSuN), 2018